Cancer News and Research

Latest Cancer News and Research

YM BioSciences-Cytopia merger complete

YM BioSciences Inc., announced that the merger of Cytopia Limited, the Australian biopharmaceutical company, into YM under a Scheme of Arrangement, has been concluded.

1 Feb 2010

Abbott signs licensing agreement with Pierre Fabre SA to develop and commercialize cancer antibody h224G11

Abbott announced today an exclusive worldwide licensing agreement with Pierre Fabre SA to develop and commercialize h224G11, a pre-clinical monoclonal antibody identified at the Centre d'Immunologie Pierre Fabre (CIPF) in France and targeting the cMet receptor for the treatment of cancer.

1 Feb 2010

First Edition: February 1, 2010

As President Obama's proposed budget heads to Congress, analysis of the breakdown of health reform -- and whether it may still have a chance -- continues.

1 Feb 2010

Managing Myeloma reviews past accomplishments; discusses future goals in evolving therapeutic landscape

Managing Myeloma (www.ManagingMyeloma.com) convened the 2010 Multidisciplinary Advisory Board on January 16, 2010 to review the past 18 months and discuss the educational and practical needs of myeloma practitioners in an evolving therapeutic landscape.

1 Feb 2010

New testing method for early detection of cancer

A new testing method is being developed to detect cancer soon after the tumor has formed. It will identify characteristic substances in the blood which accompany a certain type of tumor. The first steps in the development have already been completed.

1 Feb 2010

Humana announces consolidated revenues of $7.63 billion for fourth-quarter 2009

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended December 31, 2009 (4Q09) of $1.48, as compared to $1.03 per share for the quarter ended December 31, 2008 (4Q08), reflecting lower PDP claim expenses in 4Q09 than in 4Q08.

1 Feb 2010

Belfast scientists identify gene that can help predict tamoxifen treatment failure

Scientists in Belfast have identified a gene which could predict whether women with breast cancer will respond to treatment with tamoxifen, according to findings published today in Cancer Research.

1 Feb 2010

Asuragen enters into research agreements to develop microRNA-based diagnostic test

Asuragen, Inc., a leader in molecular diagnostics and RNA-based pharmacogenomics services, announced today that it has entered into research agreements with The University of Pittsburgh Medical Center, Brigham and Women’s Hospital, the H. Lee Moffitt Cancer Center, Dartmouth’s Hitchcock Medical Center and the University of Sherbrooke to develop a microRNA-based diagnostic test to aid the detection of pancreatic cancer from fine-needle aspirate (FNA) biopsies.

1 Feb 2010

Ipsen reports consolidated group sales of €1,032.8M for 2009

Ipsen reported today its sales for the fourth quarter and full year 2009.

1 Feb 2010

Epigenetics may help determine CT radiation risk to patients' offsprings

There remains a lack of consensus amongst the medical and scientific communities about any cancer risk from low level radiation, particularly low-dose radiation delivered from computed tomography (CT) scans. However, the study of epigenetics may play a role in determining whether or not future trends of diseases can in fact be linked to utilization of CT, according to an article in the February issue of the Journal of the American College of Radiology (JACR).

1 Feb 2010

Researchers to assess any cancer risk associated with low-dose radiation exposure from medical imaging tests

Researchers at the National Institutes of Health (NIH) Clinical Center are incorporating radiation dose exposure reports into the electronic medical record, an effort that they hope will lead to an accurate assessment of whether any cancer risk is associated with low-dose radiation exposure from medical imaging tests, according to an article in the February issue of the Journal of the American College of Radiology (JACR).

1 Feb 2010

Study analyzes relationship between parents' and children’s' dental visits

Whether or not children receive regular dental care is strongly associated with their parents' history of seeking dental care. A new report to appear in the journal Pediatrics, which has been released online, is the first to analyze the relationship between parents' and childrens' dental visits in a nationally represntative sample.

1 Feb 2010

IpAuctions to auction Predicant Biosciences patents, certain intellectual property of Perlegen

IpAuctions, Inc. is selling the patents and patent applications developed by Predicant Biosciences, formerly called BioSpect, and certain intellectual property of Perlegen.

1 Feb 2010

New mental health coverage rules promise to end some discrimination

Reuters: Employer-provided group health plans must offer the same level of coverage for mental illness and drug abuse treatment as for other ailments, according to federal regulations issued on Friday.

31 Jan 2010

KMW's Marni Fund raises nearly $450,000 for breast cancer research

Darren Levine's wife Marni Elise Levine passed away from breast cancer at the young age of 37. She was an inspiration to all and the highest ranking female Krav Maga instructor in the United States. After her passing in 2006, KMW established the “Marni Fund” in conjunction with the Stop Cancer Organization. KMW puts on special self-defense seminars worldwide with 100% of the proceeds from the seminars donated to the Marni Fund.

30 Jan 2010

Noninvasive optical imaging probes to determine amount and type of cell death in tumors

For quite some time, the "Holy Grail" in medical imaging has been the development of an effective method to image cell death as a means to intervene early in diseases and rapidly determine the effectiveness of treatments. A new paper by researchers at the University of Notre Dame and the Washington University School of Medicine describes important progress in using a synthetic probe to target dead and dying cells in mammary and prostate tumors in living animals.

30 Jan 2010

Society publication strengthens oncology journals program

Beginning this year, Springer will add the Journal of Cancer Education (JCE) to its journals publishing program. Published on behalf of the American Association for Cancer Education and the European Association for Cancer Education, the quarterly journal features a varied editorial board made up of MDs and PhDs who support the dissemination of information on improving cancer education worldwide.

30 Jan 2010

LIVESTRONG and Nike form new strategy to raise global awareness on fight against cancer

Today LIVESTRONG® and NIKE, Inc. announced a new strategy for Nike’s LIVESTRONG product collection that will increase the partnership’s innovative efforts to raise awareness for the cancer fight globally and expand sales internationally.

30 Jan 2010

U.S. Marshals seize unapproved ozone generators from Applied Ozone Systems

At the request of the U.S. Food and Drug Administration, U.S. Marshals today seized 79 ozone generators, models AOS-1M and AOS-1MD, from Applied Ozone Systems of Auburn, Calif. The seized goods, which are medical devices, are valued at $75,900.

30 Jan 2010

LiveData OR-Dashboard completes 2010 IHE North American Connectathon

LiveData, a leading innovator in real-time data integration and display, today announced that the technology underlying LiveData OR-Dashboard, has successfully completed the 2010 IHE North American Connectathon, a proving ground for medical device integration.

30 Jan 2010

Cancer News and Research

Latest Cancer News and Research

YM BioSciences-Cytopia merger complete

Abbott signs licensing agreement with Pierre Fabre SA to develop and commercialize cancer antibody h224G11

First Edition: February 1, 2010

Managing Myeloma reviews past accomplishments; discusses future goals in evolving therapeutic landscape

New testing method for early detection of cancer

Humana announces consolidated revenues of $7.63 billion for fourth-quarter 2009

Belfast scientists identify gene that can help predict tamoxifen treatment failure

Asuragen enters into research agreements to develop microRNA-based diagnostic test

Ipsen reports consolidated group sales of €1,032.8M for 2009

Epigenetics may help determine CT radiation risk to patients' offsprings

Researchers to assess any cancer risk associated with low-dose radiation exposure from medical imaging tests

Study analyzes relationship between parents' and children’s' dental visits

IpAuctions to auction Predicant Biosciences patents, certain intellectual property of Perlegen

New mental health coverage rules promise to end some discrimination

KMW's Marni Fund raises nearly $450,000 for breast cancer research

Noninvasive optical imaging probes to determine amount and type of cell death in tumors

Society publication strengthens oncology journals program

LIVESTRONG and Nike form new strategy to raise global awareness on fight against cancer

U.S. Marshals seize unapproved ozone generators from Applied Ozone Systems

LiveData OR-Dashboard completes 2010 IHE North American Connectathon

Understanding the DNA Damage Response in Innate Immunity eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in